dry eye disease
Showing 51 - 75 of 149
Dry Eye Disease, Sjögren Syndrome Trial in United States (Tivanisiran sodium ophthalmic solution, Vehicle ophthalmic solution)
Recruiting
- Dry Eye Disease
- Sjögren Syndrome
- Tivanisiran sodium ophthalmic solution
- Vehicle ophthalmic solution
-
Birmingham, Alabama
- +38 more
Sep 15, 2022
Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)
Completed
- Dry Eye Disease
- CequaTM (Cyclosporine 0.09%) ophthalmic solution
-
Fort Myers, Florida
- +4 more
Sep 8, 2022
Multimodal Screening of Dry Eye Disease
Recruiting
- Dry Eye Disease
- No Dye BreakUp Time
-
Le Kremlin-Bicêtre, Val De Marne, FranceOpthtalmology Departement, Bicêtre Hospital
Sep 5, 2022
Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in United States (Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine
Completed
- Dry Eye Disease
- Kerato Conjunctivitis Sicca
- Pilocarpine Ophthalmic Topical Cream, Dose 1
- +3 more
-
Chandler, Arizona
- +18 more
Aug 26, 2022
Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- OTX-101 0.05%
- +2 more
-
Cleveland, Ohio(unnamed)
Aug 26, 2022
Dry Eye Disease Trial in Venice (Varenicline solution, Placebo nasal spray (OC-01 Vehicle Nasal Spray))
Recruiting
- Dry Eye Disease
- Varenicline solution
- Placebo nasal spray (OC-01 Vehicle Nasal Spray)
-
Venice, FloridaStephenson Eye Associates
Aug 23, 2022
Dry Eye Disease Trial in China (Varenicline Tartrate Nasal Spray, Placebo (vehicle))
Recruiting
- Dry Eye Disease
- Varenicline Tartrate Nasal Spray
- Placebo (vehicle)
-
Hefei, Anhui, China
- +19 more
Aug 16, 2022
Dry Eye Disease Trial in Newport Beach (0.003% AR-15512 to be administered in both eyes, Vehicle to be administered in both
Completed
- Dry Eye Disease
- 0.003% AR-15512 to be administered in both eyes
- Vehicle to be administered in both eyes
-
Newport Beach, CaliforniaEye Research Foundation
Aug 9, 2022
Dry Eye Disease Trial (AR-15512 Ophthalmic Solution, Vehicle)
Not yet recruiting
- Dry Eye Disease
- AR-15512 Ophthalmic Solution
- Vehicle
- (no location specified)
Aug 5, 2022
Dry Eye Disease, Meibomian Gland Dysfunction Trial in New York, Harrisburg (IPL_RF_MGX)
Recruiting
- Dry Eye Disease
- Meibomian Gland Dysfunction
- IPL_RF_MGX
-
New York, New York
- +1 more
Aug 1, 2022
Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution
Recruiting
- Dry Eye Disease
- SY-201 Ophthalmic Solution 2.0%
- +3 more
-
Durham, North CarolinaLexitas
Jul 27, 2022
Dry Eye Disease, Cataract Trial in Valladolid (Systane Hydration lubricant eye drops)
Recruiting
- Dry Eye Disease
- Cataract
- Systane Hydration lubricant eye drops
-
Valladolid, SpainPrincipal Investigator
Jul 11, 2022
Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye
Recruiting
- Dry Eye Disease
- Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
-
Oslo, NorwayThe Norwegian Dry Eye Clinic
Jun 27, 2022
Dry Eye Disease Trial in United States (Tivanisiran sodium ophthalmic solution, Vehicle ophthalmic solution)
Recruiting
- Dry Eye Disease
- Tivanisiran sodium ophthalmic solution
- Vehicle ophthalmic solution
-
Chandler, Arizona
- +24 more
Jun 24, 2022
Dry Eye Disease Trial in Mexico City (OC-01 0.1% 0.6 mg/ml, OC-01 (varenicline) nasal spray: 0.2 % (1.2 mg/ml), comparator)
Completed
- Dry Eye Disease
- OC-01 0.1% 0.6 mg/ml
- +2 more
-
Mexico City, MexicoMexico City
Mar 8, 2022
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface
Recruiting
- Dry Eye Disease
- oGVHD
- The standard care exam and biological specimens' collection
-
Baltimore, MarylandGeenebaum Cancer Center, University of Maryland Medical Center
Jun 2, 2022
Dry Eye Disease Trial in Patras (Oxatrex)
Completed
- Dry Eye Disease
-
Patras, Achaea, GreeceDepartment of Ophthalmology, General University Hospital of Patr
Apr 14, 2022
Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium
Completed
- Dry Eye Disease
- SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
- +6 more
-
Phoenix, Arizona
- +39 more
Apr 10, 2022
Dry Eye Disease Trial in United States (Systane Complete)
Completed
- Dry Eye Disease
- Systane Complete
-
Kansas City, Missouri
- +3 more
Mar 28, 2022
Dry Eye Disease Trial in Boston (Lotemax, Soothe Tired Eyes Lubricant Eye Drop (Artificial Tears), In Vivo Confocal Microscopy
Dry Eye Disease Trial in Andover, Raynham, Memphis (ST-100 Ophthalmic Solution, Placebo Ophthalmic Solution)
Completed
- Dry Eye Disease
- ST-100 Ophthalmic Solution
- Placebo Ophthalmic Solution
-
Andover, Massachusetts
- +2 more
Feb 22, 2022
Dry Eye Disease Trial in Seoul (Real Pulse Electrical Stimulation (NuEyne 01), Sham Pulse Electrical Stimulation)
Completed
- Dry Eye Disease
- Real Pulse Electrical Stimulation (NuEyne 01)
- Sham Pulse Electrical Stimulation
-
Seoul, Korea, Republic ofDepartment of Ophthalmology, Samsung Medical Center
Mar 7, 2022
Dry Eye Disease Trial in Louisville, Nashville (OC-02 (simpinicline) nasal spray, Placebo (vehicle) nasal spray)
Completed
- Dry Eye Disease
- OC-02 (simpinicline) nasal spray
- Placebo (vehicle) nasal spray
-
Louisville, Kentucky
- +1 more
Feb 25, 2022